These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 16905291
1. MDMA administration to pregnant Sprague-Dawley rats results in its passage to the fetal compartment. Campbell NG, Koprich JB, Kanaan NM, Lipton JW. Neurotoxicol Teratol; 2006; 28(4):459-65. PubMed ID: 16905291 [Abstract] [Full Text] [Related]
2. Sprague-Dawley rats display sex-linked differences in the pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolite 3,4-methylenedioxyamphetamine (MDA). Fonsart J, Menet MC, Debray M, Hirt D, Noble F, Scherrmann JM, Declèves X. Toxicol Appl Pharmacol; 2009 Dec 15; 241(3):339-47. PubMed ID: 19781562 [Abstract] [Full Text] [Related]
3. Interpretation of a 3,4-methylenedioxymethamphetamine (MDMA) blood level: discussion by means of a distribution study in two fatalities. De Letter EA, Bouche MP, Van Bocxlaer JF, Lambert WE, Piette MH. Forensic Sci Int; 2004 May 10; 141(2-3):85-90. PubMed ID: 15062945 [Abstract] [Full Text] [Related]
4. Sensitive determination of MDMA and its metabolite MDA in rat blood and brain microdialysates by HPLC with fluorescence detection. Tomita M, Nakashima MN, Wada M, Nakashima K. Biomed Chromatogr; 2007 Oct 10; 21(10):1016-22. PubMed ID: 17474141 [Abstract] [Full Text] [Related]
5. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans. Mas M, Farré M, de la Torre R, Roset PN, Ortuño J, Segura J, Camí J. J Pharmacol Exp Ther; 1999 Jul 10; 290(1):136-45. PubMed ID: 10381769 [Abstract] [Full Text] [Related]
6. Pharmacokinetics of dibutylphthalate in pregnant rats. Fennell TR, Krol WL, Sumner SC, Snyder RW. Toxicol Sci; 2004 Dec 10; 82(2):407-18. PubMed ID: 15456918 [Abstract] [Full Text] [Related]
7. Effects of MDMA (ecstasy) and two of its metabolites on rat embryos in vitro. Barenys M, Flick B, Boix N, Almeida B, Joglar J, Klug S, Llobet JM. Reprod Toxicol; 2012 Aug 10; 34(1):57-65. PubMed ID: 22391229 [Abstract] [Full Text] [Related]
8. Sprague-Dawley rats display metabolism-mediated sex differences in the acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy). Fonsart J, Menet MC, Declèves X, Galons H, Crété D, Debray M, Scherrmann JM, Noble F. Toxicol Appl Pharmacol; 2008 Jul 01; 230(1):117-25. PubMed ID: 18358511 [Abstract] [Full Text] [Related]
9. Stereochemical differences in the metabolism of 3,4-methylenedioxymethamphetamine in vivo and in vitro: a pharmacokinetic analysis. Cho AK, Hiramatsu M, Distefano EW, Chang AS, Jenden DJ. Drug Metab Dispos; 1990 Jul 01; 18(5):686-91. PubMed ID: 1981721 [Abstract] [Full Text] [Related]
10. Uterine position determines the extent of dopamine reduction after chronic prenatal cocaine exposure. Lipton JW, Robie HS, Ling Z, Weese-Mayer DE, Carvey PM. Ann N Y Acad Sci; 1998 May 30; 844():314-23. PubMed ID: 9668689 [Abstract] [Full Text] [Related]
11. Metabolism and disposition of cyproheptadine and desmethylcyproheptadine in pregnant and fetal rats. Chow SA, Fischer LJ. Drug Metab Dispos; 1987 May 30; 15(6):740-8. PubMed ID: 2893697 [Abstract] [Full Text] [Related]
12. Methylmercury distribution in the pregnant rat and embryo during early midbrain organogenesis. Lewandowski TA, Pierce CH, Pingree SD, Hong S, Faustman EM. Teratology; 2002 Nov 30; 66(5):235-41. PubMed ID: 12397631 [Abstract] [Full Text] [Related]
13. Post-mortem redistribution of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rabbit. Part I: experimental approach after in vivo intravenous infusion. De Letter EA, Clauwaert KM, Belpaire FM, Lambert WE, Van Bocxlaer JF, Piette MH. Int J Legal Med; 2002 Aug 30; 116(4):216-24. PubMed ID: 12185492 [Abstract] [Full Text] [Related]
14. Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat. Upreti VV, Eddington ND. J Pharm Sci; 2008 Apr 30; 97(4):1593-605. PubMed ID: 17724664 [Abstract] [Full Text] [Related]
15. Construction of a physiologically based pharmacokinetic model for 2,4-dichlorophenoxyacetic acid dosimetry in the developing rabbit brain. Kim CS, Binienda Z, Sandberg JA. Toxicol Appl Pharmacol; 1996 Feb 30; 136(2):250-9. PubMed ID: 8619233 [Abstract] [Full Text] [Related]
16. Prenatal stress affects 3,4-methylenedioxymethamphetamine pharmacokinetics and drug-induced motor alterations in adolescent female rats. Morley-Fletcher S, Puopolo M, Gentili S, Gerra G, Macchia T, Laviola G. Eur J Pharmacol; 2004 Apr 05; 489(1-2):89-92. PubMed ID: 15063159 [Abstract] [Full Text] [Related]
17. Population pharmacokinetics of 3,4-methylenedioxymethamphetamine and main metabolites in rats. Hirt D, Fonsart J, Menet MC, Debray M, Noble F, Declèves X, Scherrmann JM. Toxicol Sci; 2010 Mar 05; 114(1):38-47. PubMed ID: 20008456 [Abstract] [Full Text] [Related]
18. The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine. Karlsen SN, Spigset O, Slørdal L. Basic Clin Pharmacol Toxicol; 2008 Jan 05; 102(1):15-24. PubMed ID: 18047478 [Abstract] [Full Text] [Related]
19. Maternal and fetal brain and plasma levels of cocaine and benzoylecgonine after acute or chronic maternal intravenous administration of cocaine. Robinson SE, Enters EK, Jackson GF, Chinchilli VM, Maher JR, McDowell KP, Allen HM, Guo H. J Pharmacol Exp Ther; 1994 Dec 05; 271(3):1234-9. PubMed ID: 7996432 [Abstract] [Full Text] [Related]
20. Neurotoxicity mechanisms of thioether ecstasy metabolites. Capela JP, Macedo C, Branco PS, Ferreira LM, Lobo AM, Fernandes E, Remião F, Bastos ML, Dirnagl U, Meisel A, Carvalho F. Neuroscience; 2007 Jun 08; 146(4):1743-57. PubMed ID: 17467183 [Abstract] [Full Text] [Related] Page: [Next] [New Search]